2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$4.17+$0.04 (+0.85%)
Price as of Aug 03, 2026 11:32 AM EDT- $267.2MMarket Cap
- 22.55%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$4.17+$0.04 (+0.85%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.13 | ||
Change | -$0.10 (-2.36%) | ||
Open | $4.28 | ||
High | $4.28 | ||
Low | $4.06 | ||
Previous Close | $4.23 | ||
Volume | 409,612 | ||
30-Day Average Volume | 842,063 | ||
1-Week Change | -4.40% | ||
1-Month Change | -17.23% | ||
1-Year Change | 22.55% | ||
3-Year Change | -59.35% | ||
5-Year Change | -76.52% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $214.8M | ||
Market Cap | $267.2M | ||
Enterprise Value | $219.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.5M | ||
Free Cash Flow | -$18.5M | ||
EBIT | -$13.5M | ||
EBITDA | -$13.5M | ||
Net Working Capital | $156.4M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -20 | ||
PEG | 1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue